Pulse Biosciences Inc (PLSE)
$6.86
Performance
- $6.68$6.94$6.86
2.62%
Downside
Day's Volatility :3.68%
Upside
1.08%
- $3.78$13.62$6.86
44.9%
Downside
52 Weeks Volatility :72.25%
Upside
49.63%
Returns
| Period | Pulse Biosciences Inc | |
|---|---|---|
3 Months | -18.72% | |
6 Months | 71.93% | |
1 Year | 17.26% | |
3 Years | -68.68% |
Highlights
Market Capitalization | 370.2M |
Book Value | $0.8 |
Earnings Per Share (EPS) | -0.88 |
PEG Ratio | 0.0 |
Wall Street Target Price | 5.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -39.75% |
Return On Equity TTM | -200.46% |
Revenue TTM | -9.0K |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | -550.0K |
EBITDA | -42.4M |
Diluted Eps TTM | -0.88 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Downside of 27.11%
Technicals Summary
Sell
Neutral
Buy
Pulse Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Pulse Biosciences Inc | -19.67% | 71.93% | 17.26% | -68.68% | -58.17% |
 Intuitive Surgical, Inc. | -4.26% | 40.66% | 27.13% | 29.92% | 117.28% |
 Resmed Inc. | -4.93% | 30.8% | -18.9% | -12.86% | 79.74% |
 Becton, Dickinson And Company | -3.24% | -8.51% | -10.39% | -9.17% | -1.52% |
 West Pharmaceutical Services Inc | -0.68% | 7.75% | 8.05% | 19.64% | 215.5% |
 Alcon Ag | -4.1% | 12.21% | 10.64% | 4.52% | 37.47% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Pulse Biosciences Inc | NA | NA | 0.0 | 0.0 | -2.0 | -0.4 | NA | 0.8 |
Intuitive Surgical, Inc. | 68.07 | 68.07 | 7.13 | 6.28 | 0.16 | 0.08 | NA | 39.37 |
Resmed Inc. | 30.5 | 30.5 | 1.75 | 7.4 | 0.22 | 0.11 | 0.01 | 30.47 |
Becton, Dickinson And Company | 53.75 | 53.75 | 1.34 | 12.95 | 0.05 | 0.03 | 0.02 | 87.68 |
West Pharmaceutical Services Inc | 49.52 | 49.52 | 6.72 | 7.62 | 0.21 | 0.12 | 0.0 | 39.2 |
Alcon Ag | 41.2 | 41.2 | 4.59 | 3.06 | 0.05 | 0.02 | 0.0 | 41.81 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Pulse Biosciences Inc | Sell | $370.2M | -58.17% | NA | 0.0% |
Intuitive Surgical, Inc. | Buy | $133.8B | 117.28% | 68.07 | 27.16% |
Resmed Inc. | Buy | $27.1B | 79.74% | 30.5 | 19.77% |
Becton, Dickinson And Company | Buy | $67.7B | -1.52% | 53.75 | 6.44% |
West Pharmaceutical Services Inc | Buy | $28.6B | 215.5% | 49.52 | 20.12% |
Alcon Ag | Buy | $39.9B | 37.47% | 41.2 | 10.3% |
Institutional Holdings
BlackRock Inc
1.95%Bank of America Corp
1.45%Vanguard Group Inc
1.19%Geode Capital Management, LLC
0.69%State Street Corporation
0.56%Hovey Youngman Associates Inc
0.47%
Corporate Announcements
Pulse Biosciences Inc Earnings
Pulse Biosciences Inc’s price-to-earnings ratio stands at None
Read More
Company Information
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Organization | Pulse Biosciences Inc |
Employees | 0 |
CEO | Mr. Robert W. Duggan |
Industry | Health Technology |
